People · Operator
Named in public records as an officer, director or promoter · active 2010–2026 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aerie Pharmaceuticals Inc | — | Biotechnology | Series D+ | $189.6M | $5.2B | 2010 |
| Nuvaira, Inc. | — | Other Health Care | Series C | $177.8M | $191.8M | 2026 |
GEOFFREY J DUYK at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside GEOFFREY J DUYK on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kirk Nielsen | 1 | 13 |
| Brian Levy | 1 | 8 |
| ANAND MEHRA | 1 | 7 |
| Michael A. Carusi | 1 | 6 |
| Mark Deem | 1 | 5 |
| HENRY A. PLAIN | 1 | 5 |
| David Epstein | 1 | 5 |
| David Stassen | 1 | 5 |
| Hank Plain | 1 | 5 |
| DENNIS HENNER | 1 | 5 |
| James Mazzo | 1 | 4 |
| Gerald Cagle | 1 | 4 |
| Christopher A. Shen | 1 | 3 |
| Dave Stassen | 1 | 3 |
| DAVID GRYSKA | 1 | 3 |
| MARK A. DEEM | 1 | 3 |
| Richard Rubino | 1 | 3 |
| Mike Carusi | 1 | 3 |
| DENNIS W. WAHR | 1 | 3 |
| DENNIS J HENNER | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.